The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Does The Forecasted Market Size Of The Infectious Disease In Vitro Diagnostics Market Compare Between 2026 And 2030?
The infectious disease in vitro diagnostics market size has seen strong growth in recent years. It is anticipated to increase from $15.1 billion in 2025 to $16.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. The expansion observed historically is attributable to the global burden of infectious diseases, the broadening of hospital laboratories, the necessity for early diagnosis, advancements in immunoassays, and governmental disease control initiatives.
The infectious disease in vitro diagnostics market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $21.25 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is primarily driven by factors such as pandemic preparedness initiatives, the expansion of molecular diagnostics, increasing antimicrobial resistance, the proliferation of diagnostic laboratories, and enhanced healthcare screening efforts. Key trends anticipated for the forecast period encompass the swift adoption of molecular diagnostics, the rise of point-of-care infectious testing, advancements in high-sensitivity pathogen detection, the development of multiplex diagnostic panels, and a greater emphasis on surveillance testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30303&type=smp
Which Significant Factors Are Encouraging Growth In The Infectious Disease In Vitro Diagnostics Market?
The rising global occurrence of infectious diseases stimulated the expansion of the infectious disease in vitro diagnostics market throughout the historical timeframe. Infectious diseases pertain to the global population impacted by bacterial, viral, fungal, or parasitic infections at any given moment, thus reflecting the total disease load across communities. Changes in climate have broadened the living environments for disease-transmitting vectors like mosquitoes, contributing to an escalation in the worldwide prevalence of infectious diseases. The infectious disease in vitro diagnostics assist this pattern by offering accurate and prompt diagnostic instruments, empowering healthcare professionals to pinpoint pathogens, commence suitable treatment, and manage outbreaks with greater efficiency. As an illustration, in October 2024, data from the World Health Organization, a health authority located in Switzerland, revealed that roughly 10.8 million individuals globally contracted tuberculosis, wherein 55% were men, 33% women, and 12% children and adolescents, with people living with human immunodeficiency virus (HIV) accounting for 6.1% of these instances. Consequently, the growing worldwide prevalence of infectious diseases propelled the expansion of the infectious disease in vitro diagnostics market during the historic period.
How Is Segment Classification Applied In The Infectious Disease In Vitro Diagnostics Market?
The infectious disease in vitro diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology
3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications
4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers
2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators
3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services
What Trends Are Influencing The Infectious Disease In Vitro Diagnostics Market Outlook?
Companies operating in the infectious disease in vitro diagnostics market are focusing on developing innovative products, such as the rapid detection of multiple gastrointestinal pathogens, to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing capabilities. Rapid detection of multiple gastrointestinal pathogens refers to diagnostic tests that can quickly identify the presence of several disease-causing microorganisms in the gastrointestinal tract from a single sample. For instance, in June 2024, MP Biomedicals, a US-based provider of a diverse range of products, chemicals, and diagnostics, launched a range of immunochromatographic-based rapid diagnostic kits for gastrointestinal infectious diseases. These enable quick and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. These kits feature rapid, point-of-care qualitative detection, versatile sample use (stool, blood, plasma, serum, water, and food), and suitability for both clinical and research settings. Leveraging cutting-edge immunochromatographic technology, they support early diagnosis, monitoring of treatment effectiveness, and confirmation of pathogen eradication, representing a significant advancement in gastrointestinal health diagnostics by combining speed, precision, and broad pathogen coverage.
Who Are The Key Market Participants In The Infectious Disease In Vitro Diagnostics Market?
Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare
Access The Complete Infectious Disease In Vitro Diagnostics Market Report:
Which Region Stands As The Largest Contributor To The Infectious Disease In Vitro Diagnostics Market?
North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Infectious Disease In Vitro Diagnostics Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Infectious Disease In Vitro Diagnostics Market 2026, By The Business Research Company
Cogeneration Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/cogeneration-equipment-global-market-report
Sterilization Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report
Respiratory Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model